ERBB2 and breast carcinoma: There is an urgent need to identify the risk profile of individual breast cancers—e.g., clinical factors, histopathological factors (TNM classification, tumor grade, hormone receptor status, expression of human epidermal growth factor receptor 2 (HER2), and Ki-67)–and molecular factors that can be used in gene expression analysis panels.